Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor

被引:28
作者
Tomidokoro, Y [1 ]
Harigaya, Y [1 ]
Matsubara, E [1 ]
Ikeda, M [1 ]
Kawarabayashi, T [1 ]
Okamoto, K [1 ]
Shoji, M [1 ]
机构
[1] Gunma Univ, Sch Med, Dept Neurol, Maebashi, Gumma 371, Japan
关键词
Alzheimer's disease; A beta; transgenic mice; somatostatin; substance P; choline acetyltransferase;
D O I
10.1016/S0304-3940(00)01443-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
APPsw transgenic mice showing substantial features of brain A beta amyloidosis such as senile plaques and behavioral abnormalities were examined by immunostaining to determine whether A beta deposits could induce the subsequent disturbance of neurotransmitter systems including somatostatin, substance P and choline acety]transferase (ChAT), which are prominent in the Alzheimer's disease brain. Somatostatin, substance P and ChAT disappeared in the areas of senile plaque and were accumulated in dystrophic neurites around the amyloid cores. These findings suggest a potential role of brain A beta amyloidosis in disturbance of the neurotransmitter systems leading to memory disturbance of Alzheimer's disease. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 16 条
[1]   SUBSTANCE-P IMMUNOREACTIVITY WITHIN NEURITIC PLAQUES [J].
ARMSTRONG, DM ;
TERRY, RD .
NEUROSCIENCE LETTERS, 1985, 58 (01) :139-144
[2]   CHOLINE-ACETYLTRANSFERASE IMMUNOREACTIVITY IN NEURITIC PLAQUES OF ALZHEIMER BRAIN [J].
ARMSTRONG, DM ;
BRUCE, G ;
HERSH, LB ;
TERRY, RD .
NEUROSCIENCE LETTERS, 1986, 71 (02) :229-234
[3]   The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease [J].
Beach, TG ;
Kuo, YM ;
Spiegel, K ;
Emmerling, MR ;
Sue, LI ;
Kokjohn, K ;
Roher, AE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (04) :308-313
[4]   EVIDENCE THAT TRANSMITTER-CONTAINING DYSTROPHIC NEURITES PRECEDE THOSE CONTAINING PAIRED HELICAL FILAMENTS WITHIN SENILE PLAQUES IN THE ENTORHINAL CORTEX OF NONDEMENTED ELDERLY AND ALZHEIMERS-DISEASE PATIENTS [J].
BENZING, WC ;
BRADY, DR ;
MUFSON, EJ ;
ARMSTRONG, DM .
BRAIN RESEARCH, 1993, 619 (1-2) :55-68
[5]   CORTICAL SUBSTANCE P-LIKE IMMUNOREACTIVITY IN CASES OF ALZHEIMERS-DISEASE AND SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
CRYSTAL, HA ;
DAVIES, P .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (06) :1781-1784
[6]   REDUCED SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN CEREBRAL-CORTEX FROM CASES OF ALZHEIMER-DISEASE AND ALZHEIMER SENILE DEMENTIA [J].
DAVIES, P ;
KATZMAN, R ;
TERRY, RD .
NATURE, 1980, 288 (5788) :279-280
[7]  
DAVIES P, 1976, LANCET, V2, P1403
[8]   MODIFIED AMYLOID-BETA PROTEIN ENDING AT 42 OR 40 WITH DIFFERENT SOLUBILITY ACCUMULATES IN THE BRAIN OF ALZHEIMERS-DISEASE [J].
HARIGAYA, Y ;
SHOJI, M ;
KAWARABAYASHI, T ;
KANAI, M ;
NAKAMURA, T ;
IIZUKA, T ;
IGETA, Y ;
SAIDO, TC ;
SAHARA, N ;
MORI, H ;
HIRAI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (03) :1015-1022
[9]   Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice [J].
Hsiao, K ;
Chapman, P ;
Nilsen, S ;
Eckman, C ;
Harigaya, Y ;
Younkin, S ;
Yang, FS ;
Cole, G .
SCIENCE, 1996, 274 (5284) :99-102
[10]   APP(Sw) transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1 [J].
Irizarry, MC ;
McNamara, M ;
Fedorchak, K ;
Hsiao, K ;
Hyman, BT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (09) :965-973